Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection

NCT02527460 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Neurologic Disorders

Interventions

DRUG: Anakinra

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborators

[object Object]